These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33881707)

  • 1. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.
    Maillie L; Salgado LR; Lazarev S
    Clin Transl Oncol; 2021 Oct; 23(10):2109-2119. PubMed ID: 33881707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.
    Devecka M; Duma MN; Wilkens JJ; Kampfer S; Borm KJ; Münch S; Straube C; Combs SE
    BMC Cancer; 2020 Jun; 20(1):501. PubMed ID: 32487151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.
    Gunther JR; Rahman AR; Dong W; Yehia ZA; Kebriaei P; Rondon G; Pinnix CC; Milgrom SA; Allen PK; Dabaja BS; Smith GL
    Pract Radiat Oncol; 2017; 7(6):e401-e408. PubMed ID: 28666906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
    Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
    Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation Therapy in the Management of Leptomeningeal Disease From Solid Tumors.
    Barbour AB; Kotecha R; Lazarev S; Palmer JD; Robinson T; Yerramilli D; Yang JT
    Adv Radiat Oncol; 2024 Feb; 9(2):101377. PubMed ID: 38405313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craniospinal irradiation for leptomeningeal metastasis of solid tumors: survival analysis and prognostic factors.
    Takeda K; Umezawa R; Yamamoto T; Takahashi N; Jingu K
    J Radiat Res; 2024 Sep; 65(5):667-675. PubMed ID: 39154378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
    Yang TJ; Wijetunga NA; Yamada J; Wolden S; Mehallow M; Goldman DA; Zhang Z; Young RJ; Kris MG; Yu HA; Seidman AD; Gavrilovic IT; Lin A; Santomasso B; Grommes C; Piotrowski AF; Schaff L; Stone JB; DeAngelis LM; Boire A; Pentsova E
    Neuro Oncol; 2021 Jan; 23(1):134-143. PubMed ID: 32592583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.
    Barney CL; Brown AP; Grosshans DR; McAleer MF; de Groot JF; Puduvalli V; Tucker SL; Crawford CN; Gilbert MR; Brown PD; Mahajan A
    Neuro Oncol; 2014 Jan; 16(2):303-9. PubMed ID: 24311638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
    Ebadi M; Morse M; Gooley T; Ermoian R; Halasz LM; Lo SS; Yang JT; Blau MH; Percival ME; Cassaday RD; Graber J; Taylor LP; Venur V; Tseng YD
    J Neurooncol; 2024 Jan; 166(2):351-357. PubMed ID: 38244173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and Systemic Treatment for Leptomeningeal Disease.
    Frechette KM; Breen WG; Brown PD; Sener UT; Webb LM; Routman DM; Laack NN; Mahajan A; Lehrer EJ
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of leptomeningeal disease.
    Nguyen TK; Nguyen EK; Soliman H
    Ann Palliat Med; 2021 Jan; 10(1):909-922. PubMed ID: 32921068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study.
    Huppert LA; Fisch S; Tsopurashvili E; Somepalle SS; Salans M; Vasudevan HN; Jo Chien A; Majure M; Rugo HS; Balassanian R; Boreta L; Melisko ME
    Breast Cancer Res Treat; 2024 Aug; 206(3):625-636. PubMed ID: 38888796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report.
    Webb MJ; Breen WG; Laack NN; Leventakos K; Campian JL; Sener U
    CNS Oncol; 2023 Sep; 12(3):CNS101. PubMed ID: 37491842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and neurocognitive outcomes after cranial or craniospinal irradiation plus total-body irradiation before stem cell transplantation in pediatric leukemia patients with central nervous system involvement.
    Hiniker SM; Agarwal R; Modlin LA; Gray CC; Harris JP; Million L; Kiamanesh EF; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):67-74. PubMed ID: 24725690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity.
    Perlow HK; Matsui JK; Ewing A; Cadieux C; Dibs K; Upadhyay R; Blakaj DM; Beyer SJ; Thomas EM; Grecula JC; Raval RR; Palmer JD
    Adv Radiat Oncol; 2024 Mar; 9(3):101424. PubMed ID: 38379893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.
    Uemura S; Demizu Y; Hasegawa D; Fujikawa T; Inoue S; Nishimura A; Tojyo R; Nakamura S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Koyama J; Kawamura A; Akasaka Y; Yoshida M; Fukumitsu N; Soejima T; Kosaka Y
    Cancer Med; 2022 Mar; 11(6):1502-1510. PubMed ID: 35137555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation.
    Kun LE; Camitta BM; Mulhern RK; Lauer SJ; Kline RW; Casper JT; Kamen BA; Kaplan BM; Barber SW
    J Clin Oncol; 1984 May; 2(5):359-64. PubMed ID: 6587015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
    Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.
    El Shafie RA; Böhm K; Weber D; Lang K; Schlaich F; Adeberg S; Paul A; Haefner MF; Katayama S; Sterzing F; Hörner-Rieber J; Löw S; Herfarth K; Debus J; Rieken S; Bernhardt D
    Cancer Manag Res; 2019; 11():789-801. PubMed ID: 30697071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.